Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 4/20 | 0.73 |
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.60 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.48 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | GLP1R | P43220 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29674866 | 1.00 | SLC6A5 (0.73) | SLC6A5NOD1FAAHITGB3ITGA2B | |
| SCHEMBL29429275 | 0.99 | SLC6A5 (0.75) | SLC6A5NOD1FAAHITGB3ITGA2B | |
| SCHEMBL29429301 | 0.99 | SLC6A5 (0.75) | SLC6A5NOD1FAAHITGB3ITGA2B | |
| SCHEMBL29674915 | 0.99 | SLC6A5 (0.75) | SLC6A5NOD1FAAHITGB3ITGA2B | |
| SCHEMBL29674925 | 0.99 | SLC6A5 (0.75) | SLC6A5NOD1FAAHITGB3ITGA2B | |
| SCHEMBL29810115 | 0.92 | SLC6A5 (0.64) | SLC6A5NOD1FAAHSIRT6SIRT1 | |
| SCHEMBL9716743 | 0.89 | SLC6A5 (0.85) | SLC6A5NOD1FAAHITGB3ITGA2B | |
| SCHEMBL11213737 | 0.89 | SLC6A5 (0.85) | SLC6A5NOD1FAAHITGB3ITGA2B | |
| SCHEMBL1245563 | 0.89 | SLC6A5 (0.85) | SLC6A5NOD1FAAHITGB3ITGA2B | |
| SCHEMBL337703 | 0.89 | SLC6A5 (0.85) | SLC6A5NOD1FAAHITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114846108-B | Anti-pollution material | 日产化学株式会社 | 2024-08-20 | — | — | CN | disclosed |
| US-20230404888-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | NISSAN CHEMICAL CORPORATION (JP) | 2023-12-21 | — | — | US | disclosed |
| US-11771645-B2 | Transdermally absorbable base material containing lipid peptide compound | KYUSHU UNIVERSITY (JP) | 2023-10-03 | — | — | US | disclosed |
| CN-116744892-A | Compositions comprising a lipid peptide and a sucrose ester | 日产化学株式会社 | 2023-09-12 | — | — | CN | disclosed |
| EP-4230265-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | Nissan Chemical Corporation (JP) | 2023-08-23 | — | — | EP | disclosed |
| EP-3251656-B1 | MOISTURIZING BASE MATERIAL INCLUDING LIPID-PEPTIDE COMPOUND | UNIV KYUSHU (JP) | 2023-07-05 | — | — | EP | disclosed |
| US-20230062111-A1 | ANTI-POLLUTION MATERIAL | NISSAN CHEMICAL CORPORATION (JP) | 2023-03-02 | — | — | US | disclosed |
| EP-3881823-B1 | SOLID BASE MATERIAL CONTAINING LIPID PEPTIDE COMPOUND | NISSAN CHEMICAL CORP (JP) | 2023-01-25 | — | — | EP | disclosed |
| EP-4074380-A1 | ANTI-POLLUTION MATERIAL | Nissan Chemical Corporation (JP) | 2022-10-19 | — | — | EP | disclosed |
| US-11452688-B2 | Transdermally absorbable base material containing lipid peptide compound | KYUSHU UNIVERSITY (JP) | 2022-09-27 | — | — | US | disclosed |
| WO-2022168894-A1 | CLOTH OR PAPER ANTI-POLLUTION MATERIAL | 日産化学株式会社 | 2022-08-11 | — | — | WO | disclosed |
| CN-114846108-A | Anti-pollution material | 日产化学株式会社 | 2022-08-02 | — | — | CN | disclosed |
| EP-4014958-A1 | COATING FILM-FORMING COMPOSITION | Nissan Chemical Corporation (JP) | 2022-06-22 | — | — | EP | disclosed |
| WO-2022092284-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | 日産化学株式会社 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022065433-A1 | COSMETIC FOR HAIR | 日産化学株式会社 | 2022-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230404888-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | CUTA, SCAMP3, SURF4 | SLC6A5 1995/4885NOD1 4669/4885FAAH 1817/4885 |
| US-20230062111-A1 | ANTI-POLLUTION MATERIAL | PLIN3, CUTA, PLIN5 | SLC6A5 4156/4885NOD1 4867/4885FAAH 2926/4885 |
| US-11771645-B2 | Transdermally absorbable base material containing lipid peptide compound | NGLY1, NR1H4, HRH1 | SLC6A5 1157/4885NOD1 2199/4885FAAH 8/4885 |
| US-11452688-B2 | Transdermally absorbable base material containing lipid peptide compound | NGLY1, NR1H4, HRH1 | SLC6A5 1157/4885NOD1 2199/4885FAAH 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.